Aim. Neuropathic pain affects 7–10% of the population, with most of the patients receiving
inadequate and incomplete treatment. Owing to the high financial burden and the poor …

Pain can become a chronic and deliberating experience with a significant burden. In
preclinical and clinical studies, Saffron (Crocus sativus L.) has shown analgesic activities …

Mesenchymal stem cells (MSCs), which are isolated from adipose tissue (AD-MSCs),
umbilical cord (UC-MSCs), or bone marrow, have therapeutic potential including anti …

Neuropathic pain, which is initiated by a malfunction of the somatosensory cortex system,
elicits inflammation and simultaneously activates glial cells that initiate neuroinflammation …

Neuropathic pain (NP) is caused by a lesion or a condition that affects the somatosensory
system. Pathophysiologically, NP can be ascribed to peripheral and central sensitization …

Painful neuropathy is a common adverse effect of oxaliplatin (OXL), a platinum‐derivative
chemotherapeutic agent. Oxidative stress and mitochondrial dysfunction are key factors …

Aims Trigeminal neuralgia (TN) is a type of chronic orofacial pain evoked by trivial stimuli
that manifests as episodes of excruciating and sudden, recurrent paroxysmal pain. Most …

Objective Neuropathic pain has been considered as one of the most serious chronic pain
subtypes and causes intolerable suffering to patients physically and mentally. This study …

The currently available drugs to treat neuropathic pain do not provide adequate pain
management. As such, other treatments including stem cells, platelet-rich plasma and …

Background A somatosensory nerve lesion or disease causes neuropathic pain. Presently,
prescribed treatments are unsatisfactory or ineffective. The kernel oil of the apricot tree …